Resource Logo

Pathology of chronic myelopathy associated with HTLV-I infection (HAM/TSP).


J Neurol Sci. 1990 Apr;96(1):103-23. Unique Identifier : AIDSLINE

The CNS pathology of 10 autopsy cases of Japanese HAM/TSP patients with a serological confirmation of HTLV-I infection was reviewed. The essential histopathological feature was a chronic progressive inflammatory process with marked parenchymal exudation of lymphocytes and monocytes into both the grey and white matter of the spinal cord, uniquely perpetuating for more than 3 years after the onset of neurological symptoms, and resulting in severe degeneration of the white matter accompanied by marked glio-mesenchymal tissue reactions. Both the inflammation and the white matter degeneration were most conspicuous in the lower thoracic cord. The lateral column was always and most severely affected. Although the parenchymal tissue degeneration was not confined to any particular long tracts, symmetrical degeneration of the lateral pyramidal tract was evident in all cases. Diffuse myelin pallor was also seen in the anterior column but it was usually mild. The posterior column was commonly involved but the severity and extent of the white matter degeneration were variable. Neurons were relatively well preserved. These histopathological features of HAM/TSP in Japan largely agree with those previously described for HAM/TSP in tropical regions. In the absence of detectable amount of HTLV-I antigens at the sites of inflammation, chronic progressive parainfectious myelitis seems to be the most appropriate descriptive term for this unique histopathology of HAM/TSP.

Aged Chronic Disease Female Human Japan Male Middle Age Paraparesis, Tropical Spastic/*COMPLICATIONS/ETHNOLOGY/IMMUNOLOGY Spinal Cord Diseases/ETHNOLOGY/IMMUNOLOGY/*MICROBIOLOGY Support, Non-U.S. Gov't JOURNAL ARTICLE


Information in this article was accurate in September 30, 1990. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.